Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Pro Medicus Ltd banner

Pro Medicus Ltd
OTC:PMCUF

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
OTC:PMCUF
Watchlist
Price: 114.56 USD -3.01% Market Closed
Market Cap: $12B
Write Note Create Alert Ask AI

Wall St Price Targets

PMCUF Price Forecast
Based on 15 analysts

+43% Upside
from $114.56 today

PMCUF Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for PMCUF yet.

Pro Medicus Ltd Competitors:
Price Targets

Revenue
Forecast

25% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
25% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 7 years is 15%.

What are analyst estimates?

Gross Profit
Forecast

26% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
26% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 14 years, the compound annual growth rate for Gross Profit has been 26%. The projected CAGR for the next 7 years is 15%.

What are analyst estimates?

Operating Income
Forecast

64% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
64% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 14 years, the compound annual growth rate for Operating Income has been 64%. The projected CAGR for the next 7 years is 11%.

What are analyst estimates?

Pre-Tax Income
Forecast

53% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
53% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 53%. The projected CAGR for the next 3 years is 4%.

What are analyst estimates?

Net Income
Forecast

43% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
43% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 14 years, the compound annual growth rate for Net Income has been 43%. The projected CAGR for the next 7 years is 2%.

What are analyst estimates?

Continue PMCUF Research

Summary
PMCUF intrinsic value, competitors valuation, and company profile.
DCF Valuation
PMCUF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PMCUF stock valuation using valuation multiples.
Wall St Estimates
PMCUF price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PMCUF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Pro Medicus Ltd listings:
ASX • AUD
PME
 F • EUR
PMC
 OTC • USD
PMDIY
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PMCUF's stock price target?
Price Target
163.3 USD

According to Wall Street analysts, the average 1-year price target for PMCUF is 163.3 USD with a low forecast of 91.27 USD and a high forecast of 186.78 USD.

What is the Revenue forecast for Pro Medicus Ltd?
Projected CAGR
15%

Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 7 years is 15%.

What is the Gross Profit forecast for Pro Medicus Ltd?
Projected CAGR
15%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 26%. The projected CAGR for the next 7 years is 15%.

What is the Operating Income forecast for Pro Medicus Ltd?
Projected CAGR
11%

Over the last 14 years, the compound annual growth rate for Operating Income has been 64%. The projected CAGR for the next 7 years is 11%.

What is the Pre-Tax Income forecast for Pro Medicus Ltd?
Projected CAGR
4%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 53%. The projected CAGR for the next 3 years is 4%.

What is the Net Income forecast for Pro Medicus Ltd?
Projected CAGR
2%

Over the last 14 years, the compound annual growth rate for Net Income has been 43%. The projected CAGR for the next 7 years is 2%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.